(19)
(11) EP 4 815 977 A2

(12)

(88) Date of publication A3:
31.07.2025

(43) Date of publication:
07.10.2026 Bulletin 2026/41

(21) Application number: 24866579.6

(22) Date of filing: 25.11.2024
(51) International Patent Classification (IPC): 
A61K 38/46(2006.01)
A61K 8/66(2006.01)
A61P 1/02(2006.01)
A61K 38/48(2006.01)
A61Q 11/00(2006.01)
C07K 14/00(2006.01)
(52) Cooperative Patent Classification (CPC):
A61Q 11/00; A61K 8/66; A61K 38/482; A61K 38/465; A61P 1/02; C12Y 301/01081; C12Y 304/00; C12N 9/48; C12N 9/18
(86) International application number:
PCT/CN2024/134130
(87) International publication number:
WO 2025/113371 (05.06.2025 Gazette 2025/23)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA
Designated Validation States:
GE KH MA MD TN

(30) Priority: 30.11.2023 WO PCT/CN2023/135359

(71) Applicant: Novozymes A/S
2880 Bagsværd (DK)

(72) Inventors:
  • HUANG, Hong Zhi
    Beijing 100085 (CN)
  • CAI, Xiangyu
    Beijing 100085 (CN)
  • HOFF, Tine
    2880 Bagsvaerd (DK)
  • MORANT, Marc Dominique
    2880 Bagsvaerd (DK)
  • ZHANG, Ying
    Beijing 100085 (CN)

(74) Representative: NVS EPO Representatives 
Krogshoejvej 36
2880 Bagsvaerd
2880 Bagsvaerd (DK)

   


(54) ORAL CARE COMPOSITION COMPRISING PEPTIDASE OR LACTONASE